Loss of Atrx Sensitizes Cells to DNA Damaging Agents through p53-Mediated Death Pathways

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Conte, Damiano ^a   Huh, Michael ^a   Goodall, Emma ^a,b   Delorme, Marilyne ^a,b   Parks, Robin J ^a,b   Picketts, David J ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ATRX PROTEIN; BETA GALACTOSIDASE; CERAMIDE; CISPLATIN; CRE RECOMBINASE; DEXAMETHASONE; FAS ANTIBODY; FLUOROURACIL; PROTEIN P53; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATRX GENE; CELL SURVIVAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA DAMAGE; DRUG SENSITIVITY; EMBRYO; FIBROBLAST; MACROPHAGE; MOUSE; MYOBLAST; NONHUMAN; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CISPLATIN; DNA HELICASES; FLUOROURACIL; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

ADENOVIRIDAE; MUS;

EID: 84871303890     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052167     Document Type: Article

References (61)

1. Gibbons RJ, Picketts DJ, Villard L, Higgs DR, (1995) Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell 80: 837-845.
2. Gibbons R, (2006) Alpha thalassaemia-mental retardation, X linked. Orphanet J Rare Dis 1: 15.
3. Gibbons RJ, Wada T, Fisher CA, Malik N, Mitson MJ, et al. (2008) Mutations in the chromatin-associated protein ATRX. Hum Mutat 29: 796-802.
4. Dhayalan A, Tamas R, Bock I, Tattermusch A, Dimitrova E, et al. (2011) The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9. Hum Mol Genet 20: 2195-2203.
5. Eustermann S, Yang JC, Law MJ, Amos R, Chapman LM, et al. (2011) Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin. Nat Struct Mol Biol 18: 777-782.
6. Iwase S, Xiang B, Ghosh S, Ren T, Lewis PW, et al. (2011) ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. Nat Struct Mol Biol 18: 769-776.
7. Berube NG, Smeenk CA, Picketts DJ, (2000) Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum Mol Genet 9: 539-547.
8. McDowell TL, Gibbons RJ, Sutherland H, O'Rourke DM, Bickmore WA, et al. (1999) Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. Proc Natl Acad Sci U S A 96: 13983-13988.
9. Nan X, Hou J, Maclean A, Nasir J, Lafuente MJ, et al. (2007) Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc Natl Acad Sci U S A 104: 2709-2714.
10. Cardoso C, Timsit S, Villard L, Khrestchatisky M, Fontes M, et al. (1998) Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. Hum Mol Genet 7: 679-684.
11. Tang J, Wu S, Liu H, Stratt R, Barak OG, et al. (2004) A novel transcription regulatory complex containing Daxx and the ATR-X syndrome protein. J Biol Chem 279: 20369-20377.
12. Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, et al. (2003) The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci U S A 100: 10635-10640.
13. Drane P, Ouararhni K, Depaux A, Shuaib M, Hamiche A, (2010) The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev 24: 1253-1265.
14. Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, et al. (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140: 678-691.
15. Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD (2010) Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci U S A.
16. Berube NG, Healy J, Medina CF, Wu S, Hodgson T, et al. (2008) Patient mutations alter ATRX targeting to PML nuclear bodies. Eur J Hum Genet 16: 192-201.
17. Gibbons RJ, McDowell TL, Raman S, O'Rourke DM, Garrick D, et al. (2000) Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet 24: 368-371.
18. Law MJ, Lower KM, Voon HP, Hughes JR, Garrick D, et al. (2010) ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell 143: 367-378.
19. Bagheri-Fam S, Argentaro A, Svingen T, Combes AN, Sinclair AH, et al. (2011) Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome. Hum Mol Genet 20: 2213-2224.
20. Berube NG, Mangelsdorf M, Jagla M, Vanderluit J, Garrick D, et al. (2005) The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J Clin Invest 115: 258-267.
21. Garrick D, Sharpe JA, Arkell R, Dobbie L, Smith AJ, et al. (2006) Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genet 2: e58.
22. Seah C, Levy MA, Jiang Y, Mokhtarzada S, Higgs DR, et al. (2008) Neuronal death resulting from targeted disruption of the Snf2 protein ATRX is mediated by p53. J Neurosci 28: 12570-12580.
23. Solomon LA, Li JR, Berube NG, Beier F, (2009) Loss of ATRX in chondrocytes has minimal effects on skeletal development. PLoS One 4: e7106.
24. Medina CF, Mazerolle C, Wang Y, Berube NG, Coupland S, et al. (2009) Altered visual function and interneuron survival in Atrx knockout mice: inference for the human syndrome. Hum Mol Genet 18: 966-977.
25. Hong YK, Lee NG, Lee MJ, Park MS, Choi G, et al. (2009) dXNP/DATRX increases apoptosis via the JNK and dFOXO pathway in Drosophila neurons. Biochem Biophys Res Commun 384: 160-166.
26. Lee NG, Hong YK, Yu SY, Han SY, Geum D, et al. (2007) dXNP, a Drosophila homolog of XNP/ATRX, induces apoptosis via Jun-N-terminal kinase activation. FEBS Lett 581: 2625-2632.
27. Tang J, Qu LK, Zhang J, Wang W, Michaelson JS, et al. (2006) Critical role for Daxx in regulating Mdm2. Nat Cell Biol 8: 855-862.
28. Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, et al. (2011) Altered telomeres in tumors with ATRX and DAXX mutations. Science 333: 425.
29. Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, et al. (2011) DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331: 1199-1203.
30. Steensma DP, Higgs DR, Fisher CA, Gibbons RJ, (2004) Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations. Blood 103: 2019-2026.
31. Sladek Z, Rysanek D, (2009) Expression of macrophage CD44 receptor in the course of experimental inflammatory response of bovine mammary gland induced by lipopolysaccharide and muramyl dipeptide. Res Vet Sci 86: 235-240.
32. Dobrovolskaia MA, Vogel SN, (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4: 903-914.
33. Longley DB, Harkin DP, Johnston PG, (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3: 330-338.
34. Ritchie K, Seah C, Moulin J, Isaac C, Dick F, et al. (2008) Loss of ATRX leads to chromosome cohesion and congression defects. J Cell Biol 180: 315-324.
35. Wong LH, McGhie JD, Sim M, Anderson MA, Ahn S, et al. (2010) ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res 20: 351-360.
36. Chester N, Kuo F, Kozak C, O'Hara CD, Leder P, (1998) Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene. Genes Dev 12: 3382-3393.
37. Lebel M, Leder P, (1998) A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc Natl Acad Sci U S A 95: 13097-13102.
38. Yamagata K, Kato J, Shimamoto A, Goto M, Furuichi Y, et al. (1998) Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: implication for genomic instability in human diseases. Proc Natl Acad Sci U S A 95: 8733-8738.
39. Yankiwski V, Marciniak RA, Guarente L, Neff NF, (2000) Nuclear structure in normal and Bloom syndrome cells. Proc Natl Acad Sci U S A 97: 5214-5219.
40. Aucott R, Bullwinkel J, Yu Y, Shi W, Billur M, et al. (2008) HP1-beta is required for development of the cerebral neocortex and neuromuscular junctions. J Cell Biol 183: 597-606.
41. Imreh G, Norberg HV, Imreh S, Zhivotovsky B, (2011) Chromosomal breaks during mitotic catastrophe trigger gammaH2AX-ATM-p53-mediated apoptosis. J Cell Sci 124: 2951-2963.
42. Liu XY, Gerges N, Korshunov A, Sabha N, Khuong-Quang DA, et al. (2012) Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations. Acta Neuropathol 124: 615-625.
43. Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, et al. (2012) Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 8: e1002772.
44. Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482: 226-231.
45. Jiao Y, Killela PJ, Reitman ZJ, Rasheed AB, Heaphy CM, et al. (2012) Frequent ATRX, CIC, and FUBP1 mutations refine the classification of malignant gliomas. Oncotarget 3: 709-722.
46. Eisen JA, Sweder KS, Hanawalt PC, (1995) Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. Nucleic Acids Res 23: 2715-2723.
47. Picketts DJ, Tastan AO, Higgs DR, Gibbons RJ, (1998) Comparison of the human and murine ATRX gene identifies highly conserved, functionally important domains. Mamm Genome 9: 400-403.
48. Jaskelioff M, Van Komen S, Krebs JE, Sung P, Peterson CL, (2003) Rad54p is a chromatin remodeling enzyme required for heteroduplex DNA joint formation with chromatin. J Biol Chem 278: 9212-9218.
49. Tan TL, Essers J, Citterio E, Swagemakers SM, de Wit J, et al. (1999) Mouse Rad54 affects DNA conformation and DNA-damage-induced Rad51 foci formation. Curr Biol 9: 325-328.
50. Alexiadis V, Kadonaga JT, (2002) Strand pairing by Rad54 and Rad51 is enhanced by chromatin. Genes Dev 16: 2767-2771.
51. Golub EI, Kovalenko OV, Gupta RC, Ward DC, Radding CM, (1997) Interaction of human recombination proteins Rad51 and Rad54. Nucleic Acids Res 25: 4106-4110.
52. Lebwohl D, Canetta R, (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34: 1522-1534.
53. Conte D, Holcik M, Lefebvre CA, Lacasse E, Picketts DJ, et al. (2006) Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol Cell Biol 26: 699-708.
54. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA, (1996) MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 10: 1173-1183.
55. Hogan B, Beddington R, Constantini F, E L (1994) Manipulating the mouse embryo: A laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
56. Addison CL, Hitt M, Kunsken D, Graham FL, (1997) Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J Gen Virol 78 (Pt 7): 1653-1661.
57. Anton M, Graham FL, (1995) Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression. J Virol 69: 4600-4606.
58. Ross PJ, Parks RJ (2009) Construction and characterization of adenovirus vectors. Cold Spring Harb Protoc 2009: pdb prot5011.
59. Hubberstey AV, Pavliv M, Parks RJ, (2002) Cancer therapy utilizing an adenoviral vector expressing only E1A. Cancer Gene Ther 9: 321-329.
60. Sargent KL, Ng P, Evelegh C, Graham FL, Parks RJ, (2004) Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors. Gene Ther 11: 504-511.
61. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, et al. (1996) A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A 93: 13565-13570.